Literature DB >> 443860

Human malignant melanoma antigenic properties of phenol water extracts.

L Suter, H Tilkorn, P M Kövary.   

Abstract

Tumor-associated antigens were demonstrated in phenol water extracts of human malignant melanoma by migration tests with leukocytes from melanoma patients and controls: in 25 out of 60 melanoma patients weak reactivity was observed, usually stimulation of leukocyte migration, while leukocytes from 37 controls were negative in 100 tests. The frequency of positive reactions did not differ significantly in patients with and without metastases. Humoral antibodies against antigens of phenol water extracts were not detectable in melanoma patients. Rabbits did not produce antibodies against tumor typical substances after immunization with phenol water extracts. Tumor associated antigens of phenol water extracts are presumably not targets of antitumor immune reactions that can influence the clinical course.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 443860     DOI: 10.1007/bf00417277

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  29 in total

1.  Soluble membrane antigens of human malignant melanoma cells.

Authors:  A C Hollinshead; R B Herberman; W J Jaffurs; L K Alpert; J P Minton; J E Harris
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

2.  Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.

Authors:  A Maluish; W J Halliday
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

Review 3.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

4.  Cell-mediated immunity in patients with malignant melanoma.

Authors:  R M Mackie; W G Spilg; C E Thomas; A J Cochran
Journal:  Br J Dermatol       Date:  1972-12       Impact factor: 9.302

5.  Specific responsiveness of leukocytes to soluble extracts of human tumors.

Authors:  A E Powell; A M Sloss; R N Smith; J T Makley; C A Hubay
Journal:  Int J Cancer       Date:  1975-12-15       Impact factor: 7.396

6.  Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.

Authors:  H Shiku; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

7.  Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.

Authors:  G B Bulkley; M H Cohen; P M Banks; D H Char; A S Ketcham
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

8.  Membrane associated antigens of human malignant melanoma. I. Internal labeling, detergent solubilization and characterization by homologous antisera and polyacrylamide gel electrophoresis.

Authors:  L Suter; C Sorg; C Müller; R Johannsen; E Macher
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-10

9.  Leukocyte migration inhibition by cancer patients' sera.

Authors:  A J Cochran; R M Mackie; C E Ross; L J Ogg; A M Jackson
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

10.  Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.

Authors:  J L McCoy; L F Jerome; J H Dean; E Perlin; R K Oldham; D H Char; M H Cohen; E L Felix; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1975-07       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.